MENUNews Archive
Date: 12/15/2015
Researchers have identified potential genetic alterations in penile cancer that could pave the way for targeted treatments. The new study describes a complex landscape that could suggest potential clinical trials of targeted therapies – and potential limitations in some patients.
Date: 12/10/2015
New studies add to questions about predicting whether tamoxifen will be effective in an individual breast cancer patient.
Date: 12/03/2015
Researchers at the University of Michigan have identified a potential new approach to fertility preservation for young cancer patients that addresses concerns about beginning cancer treatment immediately and the possibility of reintroducing cancer cells during the fertility preservation process.
Date: 12/02/2015
When researchers looked at different areas within an individual rectal cancer sample, they found cases in which each area contained different genetic mutations. The findings could have significant implications for treatment recommendations.
Date: 12/01/2015
The University of Michigan Rogel Cancer Center has appointed Bhramar Mukherjee, Ph.D., as associate director for population science research.
Date: 11/30/2015
Can any cancer cell form another tumor, or is it only select cancer stem cells that give rise to new cancer cells? The answer, a new study finds, is both.
Date: 11/21/2015
Combinations of a significant number of non-toxic chemicals, many of which can be found in plants and foods, may offer a chance to stop untreatable cancers and prevent disease relapse.
Date: 11/13/2015
Kura Oncology Inc., a clinical stage biopharmaceutical company that develops therapies for cancer patients, is now trading on the NASDAQ after an initial public offering.
Date: 11/10/2015
Patients being treated for breast cancer at the University of Michigan Rogel Cancer Center now have a new way to help manage the overload of information and reminders that comes with cancer diagnosis, surgery, chemotherapy or radiation treatment.
Date: 11/03/2015
When cancer cells compete with immune cells for glucose, the cancer wins. As a result, the immune T cells are not healthy and don’t have the weapons to kill the cancer.